Background and purpose: Disabling tremor might be the main cause of disability of multiple sclerosis (MS) patients. Neuromodulation with deep brain stimulation of the thalamic nucleus ventralis intermedius (Vim DBS) is a well accepted method of neurosurgical treatment of tremor related to essential tremor or Parkinson disease. Vim DBS is not widely used to control MS tremor. Material and methods: Five MS patients with tremor (3 females and 2 males) were treated with Vim DBS. Age at implantation was 37 ± 5 years. MS lasted from 5 to 12 years (mean 6) and tremor was the main cause of disability of those patients from 2 to 5 years (mean 3) before surgery. Clinical condition of the group was evaluated with spirography, the modified Fahn scale and the modified Activity of Daily Living (ADL) scale. Evaluations were performed before surgery and 3 months after surgery. MRI exclusion criteria were the presence of a thalamic hyperintense signal in T2-weight ed images or ventricular enlargement. The procedures of implantation were performed under local and general anaesthesia. Results: Intensity of contralateral limb tremor during intraoperative macrostimulation was reduced in the whole group. The therapeutic effect of DBS was maintained at three-month follow-up. Mean contralateral limb tremor reduction was 40%. Mean ADL score improved by 18%. No mortality or morbidity was reported in the group.
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Thalamic deep brain stimulation for tremor among multiple sclerosis patients
G³êboka stymulacja wzgórza w leczeniu dr¿enia w przebiegu stwardnienia rozsianego 
Introduction
A large group of multiple sclerosis (MS) patients suffers from medically refractory severe tremor. If the tremor is responsible for the patient's disability, surgical treatment might be an option. The complex neurological syndrome of MS and relapsing and remitting character of the disease result in unclear incidence and prevalence of disabling tremor among MS patients [1] [2] [3] [4] [5] . The efficacy of thalamotomy and of deep brain stimulation of the thalamic nucleus ventralis intermedius (Vim DBS) are comparable. The higher complication rate of thalamotomy favours Vim DBS, especially if the procedure is performed bilaterally. Numerous studies have been undertaken to evaluate efficacy and to standardize the protocol for treatment of MS-related tremor but no consensus has been reached. Differentiation of tremor and cerebellar ataxia might play the key role in successful treatment [1, 2, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . The authors present a group of patients treated with Vim DBS for MS-related tremor.
Material and methods
Five MS patients with tremor, including 3 females and 2 males, were qualified for Vim DBS. Consent forms were signed by patients and their caregivers. Mean age at implantation was 37 ± 5 years. MS lasted from 5 to 12 years (mean 6 years). As reported, tremor remained the main cause of patients' disability from 2 to 5 years (mean 3 years). Clinical condition of the group was evaluated with spirography, the modified Fahn scale and the modified Activity of Daily Living (ADL) scale [19] [20] [21] [22] . Treatment was restricted to patients with secondary progressive MS, without superimposed relapses prior to surgery. To be qualified for the surgery, patients had to have a history of pharmacologically resistant upper extremity tremor that lasted unchanged for at least six months. The patients were excluded from the study if the upper extremity motor strength was less than 4/5. MRI exclusion criteria were the presence of thalamic hyperintense signal in T2-weighted images and ventricular enlargement (hydrocephalus ex vacuo). The implantations were performed under local and general anaesthesia. The target point was identified with the indirect method followed by microrecording and macrostimulation [23] [24] [25] . When the target was identified, permanent electrodes were implanted under fluoroscopic guidance. The DBS was initiated on the first day following surgery. Initial parameters of the monopolar stimulation were set at the frequency of 130 Hz with pulse width of 90 μs and mean amplitude of 2 V. The parameters were readjusted over time according to the clinical effects. If needed, the stimulation parameters were changed to bipolar, the frequency was increased up to 185 Hz, pulse width was increased up to 180 μs and the amplitude was increased up to 3.6 V. Evaluations were performed before surgery and 3 months after surgery. All of the preoperative and postoperative tests were video recorded to allow subsequent double-blinded evaluation.
Results
Intensity of contralateral limb tremor was reduced intraoperatively within the whole group. Reduction of tremor after initialization of the stimulation was reported in the whole group as well. At 3-month follow-up, mean upper limb tremor reduction was 40% on the Conclusions: The study confirms the value and safety of Vim DBS for treatment of MS-related tremor. Further study on a larger population and introduction of a qualification protocol might increase efficacy of the treatment.
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Wyniki: OEródoperacyjnie obserwowano zmniejszenie nasilenia dr¿enia u wszystkich chorych. Efekt stymulacji utrzymywa³ siê w trzymiesiêcznej obserwacji. OErednie zmniejszenie nasilenia dr¿enia w badanej grupie oceniano na 40%. Wyniki uzyskane w skali ADL uleg³y poprawie o 18%. Nie stwierdzano powik³añ leczenia w badanej grupie. Wnioski: Przedstawione wyniki leczenia dr¿enia u chorych na SR potwierdzaj¹ bezpieczeñstwo oraz skutecznooeae Vim DBS. Zwiêkszenie grupy chorych leczonych t¹ metod¹ oraz wprowadzenie protoko³u kwalifikacyjnego mo¿e zwiêk-szyae skutecznooeae omawianej terapii.
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Thalamic DBS for tremor in multiple sclerosis 5-grade Fahn scale. In spirography, tremor was reduced by 5-75%. Mean ADL score improved by 18% (Table 1) . No mortality or morbidity related to the surgery or stimulation itself was reported within the group.
Discussion
Tremor is recognized as a poor prognostic factor for MS patients. The prevalence of tremor among MS patients is estimated at 32%, and it is recognized to be the main cause of disability among 6% of them. Even though 40 years have passed since Cooper reported a positive effect of DBS on MS tremor, no qualification protocol has been developed yet. Lack of objective tools of MS tremor evaluation is one of many reasons why the consensus has not been established [1] [2] [3] [4] [5] . Poor results of conservative treatment force the introduction of invasive, neurosurgical therapy in treatment of MS-related tremor. The only effective surgical alternative of MS tremor treatment to Vim DBS is thalamotomy. The efficacy of both methods in tremor reduction is similar, but irreversible adverse events that might appear after ablative procedures, especially if performed bilaterally, draw attention to the less invasive neuromodulatory method, Vim DBS. The ethical question of whether a lesion can or should be performed on a morphologically affected MS brain is another aspect highlighted by some authors [1,4,6,8,10,11,15,18,19] .
The aetiology of MS tremor is still not well understood. It is suspected that lesions in the cerebellum or cerebro-thalamic pathways are responsible for kinetic tremor, but complex morphological changes make precise identification of lesions related to tremor in MRI or autopsy impossible. The role of sparing dopaminergic pathways by the MS process and lack of improvement after l-dopa might be important but are still not clear in the pathophysiology of MS tremor. Frequent symmetrical, bilateral manifestation of tremor among MS patients might indicate more complex pathophysiological processes underlying the tremor. The mechanism of bilateral manifestation might be only partially explained by symmetrical changes observed in the cerebellum or thalamus [5, [12] [13] [14] [17] [18] [19] .
Complex neurological symptoms in MS make description of the type of tremor difficult. Numerous techniques and rating scales have been used to evaluate MS tremor, but their reliability and validity have not been proven to be objective. Sophisticated tools and mathematical models created to analyse MS tremor have not been widely used, mostly because of their complexity and poor standardization [2] [3] [4] . The progressive character of the disease and risk of exacerbations influence evaluation of tremor and neurological syndrome, both before and after surgery [1, 2, 4] .
The increasing number of patients qualified for Vim DBS in numerous centres indicates that there is a high demand for treatment of MS-related tremor. Risk related to the surgery in this group of patients is relatively high. Long lasting, two-stage surgery that requires implantation of a foreign body might affect labile MS patients, where the immunological response plays an important role in the course of the disease [17] [18] [19] . We did not observe any MS relapses, but the risk of deterioration not directly related to the surgery (such as haematoma or infection) but to the relapse of MS should not be forgotten. Theoretically, higher risk of post-surgical infection among patients treated with immunosuppressants should be taken into account as well [3, 4, 11, 18] . 2. Even though Vim DBS carries a small risk of complications, the treatment should be restricted to patients severely disabled by tremor, in whom other neurological deficits do not significantly impair patients' quality of life.
3. A study on a larger group of patients and longer follow-up might result in a clear qualification protocol that would increase the efficacy of the treatment.
